Information Provided By: 
Fly News Breaks for August 1, 2019
DXCM
Aug 1, 2019 | 09:14 EDT
Cowen analyst Doug Schenkel noted DexCom posted another beat and raise quarter with particularly impressive patient commentary. The analyst believes Libre 2 will likely be approved shortly but regardless, he believes the company is poised to continue to materially exceed expectations. He said he would be a buyer of any weakness in the second half of the year and it should remain a long-term core holding. Schenkel reiterated his Outperform rating and $175 price target on DexCom shares.
News For DXCM From the Last 2 Days
There are no results for your query DXCM
